Avanos Medical, Inc.AVNSNYSE

Revenue (LTM)

$701M

+1.9% YoY

Net Income (LTM)

$-68M

+82.7% YoY

Free Cash Flow

$43M

Revenue CAGR (5Y)

-0.4%

—Marginsstable

FCF$0.0B

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	745	684↓8.1%	673↓1.6%	688↑2.2%	701↑1.9%
Gross Profit	380	394↑3.8%	380↓3.7%	381↑0.4%	349↓8.5%
Operating Income	87	42↓51.7%	65↑55.1%	40↓38.5%	-62↓254.0%
Net Income	6	51↑701.6%	-62↓222.4%	-392↓534.5%	-68↑82.7%
EBITDA	49	78↑59.1%	51↓35.0%	-346↓783.0%	-33↑90.4%
EPS Diluted	0.13	1.07↑723.1%	-1.33↓224.3%	-8.53↓541.4%	-1.46↑82.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	119	128↑7.8%	88↓31.3%	108↑22.8%	90↓16.6%
Total Current Assets	428	624↑46.0%	487↓22.0%	393↓19.2%	355↓9.7%
Total Assets	1,604	1,787↑11.4%	1,692↓5.3%	1,154↓31.8%	1,074↓7.0%
Total Current Liabilities	139	191↑37.2%	235↑22.8%	166↓29.3%	165↓0.4%
Total Liabilities	333	496↑48.9%	456↓8.0%	326↓28.6%	296↓9.3%
Total Equity	1,271	1,291↑1.6%	1,236↓4.3%	829↓33.0%	778↓6.1%
Total Debt	188	277↑47.7%	209↓24.5%	170↓18.6%	129↓24.1%
Net Debt	69	149↑116.4%	121↓18.7%	63↓48.5%	39↓37.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	87	91↑4.1%	32↓64.4%	101↑210.8%	75↓25.8%
Capital Expenditure	-21	-19↑8.1%	-18↑7.8%	-18↓0.0%	-32↓77.5%
Free Cash Flow	66	72↑8.0%	15↓79.6%	83↑467.8%	43↓48.0%
Stock-Based Comp	13	16↑20.5%	16↓0.6%	14↓12.7%	0
Net Change in Cash	7	9↑31.4%	-40↓534.8%	20↑150.0%	-18↓189.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance